Devalingam Mahalingam
15PUBLICATIONS
112CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Apr 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial.Devalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro
|Apr 06, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.Komal Jhaveri, Lisa D Eli, Sara A Hurvitz
|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.Ezra Y Rosen, Timothy A Yap, Elisa Fontana
|Aug 28, 2025
Clinical and Molecular Differences Suggest Different Responses to Immune Checkpoint Inhibitors in Microsatellite-Stable Solid Tumors with High Tumor Mutational Burden.Imran Nizamuddin, Tarik Demir, Katrina Dobinda
|Jul 10, 2025
DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B.Keun-Wook Lee, Devalingam Mahalingam, Byoung Yong Shim
Pageof 3
Frequent Collaborators
3 joint publications
Samuel J Klempner
3 joint publications
Benedito A Carneiro
2 joint publications
Pamela N Munster
2 joint publications
Byoung Yong Shim
2 joint publications
Jing Watnick
2 joint publications
Andrea Bullock
2 joint publications
Tarik Demir
2 joint publications
Francis J Giles
2 joint publications
Andrés Cervantes
2 joint publications
Vaibhav Sahai